While blockbuster drugs like Wegovy and Zepbound are known for helping people lose weight, 44-year-old Paige Gordon is part of a new wave of people using them to treat their eating disorders instead. So far, the research is limited.

The Health newsletter takes you inside what’s new in health, medicine and personal well-being. If you’re not subscribed, sign up here.

WSJ Future of Health returns to Washington, D.C.
Join the most influential voices across government, industry, venture capital and public health on Oct. 7 in Washington, D.C., for vital cross-sector conversations on the urgent issues reshaping American medicine—from GLP-1s and AI diagnostics to mental health, longevity, the loneliness epidemic and the spiraling cost of care. Learn more here.